SCHEMBL23930976

SCHEMBL23930976

CCCCn1cncc1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
TDP1 Q9NUW8 2/20 0.40
PDE4A P27815 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
KMT2A Q03164 2/20 0.36
POLB P06746 1/20 0.36
HCAR3 P49019 1/20 0.35
LMNA P02545 3/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6701818 0.95 TDP1 (0.39) ALDH1A1TDP1PDE4AADORA2AADORA2B
SCHEMBL23930932 0.82 CYP11B1 (0.51) ALDH1A1TDP1L3MBTL1POLBCYP1A2
SCHEMBL9819383 0.82 ALDH1A1 (0.44) ALDH1A1TDP1L3MBTL1LMNACYP1A2
SCHEMBL1422382 0.81 ALDH1A1 (0.36) ALDH1A1TDP1HCAR3KDM4CCYP11B1
SCHEMBL27922993 0.79 ADORA2A (0.40) ALDH1A1TDP1PDE4AADORA2AADORA2B
SCHEMBL5726023 0.78 CYP11B1 (0.50) TDP1KMT2ACYP1A2KDM4EMEN1
SCHEMBL15202361 0.76 GABRA1 (0.47) ALDH1A1LMNACYP1A2CYP3A4NFKB1
SCHEMBL8799103 0.76 CYP11B1 (0.49) TDP1KMT2ALMNACYP1A2KDM4E
SCHEMBL5514651 0.76 HTT (0.47) ALDH1A1POLBKDM4ETSHRCYP11B1
SCHEMBL5105361 0.75 PDE4A (0.35) PDE4AADORA2AADORA2BPDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215545-A1 ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 WO disclosed
CN-103003262-A Nitrogenated aromatic heterocyclic ring derivative KYOWA HAKKO KIRIN CO LTD 2013-03-27 CN disclosed